tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Alec Stranahan, 48 are a BUY (59.26%), 14 are a SELL (17.28%), 19 are a HOLD (23.46%).
Analyst Alec Stranahan, currently employed at BAML, carries an average stock price target met ratio of 42.38% that have a potential upside of 29.95% achieved within 161 days.
Alec Stranahan’s has documented 160 price targets and ratings displayed on 21 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AGIO, Agios Pharm at 21-Sep-2026.
Analyst best performing recommendations are on NVAX (NOVAVAX).
The best stock recommendation documented was for NVAX (NOVAVAX) at 5/10/2024. The price target of $12 was fulfilled within 3 days with a profit of $3.12 (35.14%) receiving and performance score of 117.12.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 03-Jun-2019
$15
$13.35 (809.09%)
1 years 2 months 21 days ago
(15-Jul-2025)
10/12 (83.33%)
$10.24 (215.13%)
439
Buy Since 11-Nov-2024
$36
1 years 3 months 5 days ago
(01-Jul-2025)
0/3 (0%)
$28.31 (368.14%)
Buy Since 04-Nov-2022
$48
$42.91 (843.03%)
2 years 2 months 4 days ago
(02-Aug-2024)
0/3 (0%)
$28.8 (150.00%)
Buy Since 24-Mar-2020
3 years 11 months 2 days ago
(04-Nov-2022)
1/2 (50%)
$-43.04 (-72.90%)
273
Buy Since 23-Aug-2022
$15
$9.91 (194.70%)
$228
4 years 1 months 13 days ago
(23-Aug-2022)
1/3 (33.33%)
$-38.28 (-71.85%)
119
Which stock is Alec Stranahan most bullish on?
Which stock is Alec Stranahan most reserved on?
What Year was the first public recommendation made by Alec Stranahan?
